Modes de traitement en situation réelle et prise d'analgésiques et d'anti-inflammatoires d'appoint chez les patients atteints de rhumatisme psoriasique et traités par des inhibiteurs de l'IL-17A aux États-Unis
J Manag Care Spec Pharm. 2022 doi: 10.18553/jmcp.2022.22144
In this study ixekizumab and secukinumab patients had similar treatment patterns. It was also surmised that the use of adjunctive pain and anti-inflammatory medications were similar between therapies. In coming to this conclusion investigators aimed to compare treatment patterns and use of pain and anti-inflammatory medications between patients with PsA initiating ixekizumab and secukinumab in two cohorts of patients from…(add here where is the population coming from).
Keywords:
